233 related articles for article (PubMed ID: 24987942)
1. Effects of omega-3 fatty acids on depression and quality of life in maintenance hemodialysis patients.
Dashti-Khavidaki S; Gharekhani A; Khatami MR; Miri ES; Khalili H; Razeghi E; Hashemi-Nazari SS; Mansournia MA
Am J Ther; 2014; 21(4):275-87. PubMed ID: 24987942
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 polyunsaturated fatty acids and psychological intervention for workers with mild to moderate depression: A double-blind randomized controlled trial.
Tayama J; Ogawa S; Nakaya N; Sone T; Hamaguchi T; Takeoka A; Hamazaki K; Okamura H; Yajima J; Kobayashi M; Hayashida M; Shirabe S
J Affect Disord; 2019 Feb; 245():364-370. PubMed ID: 30423463
[TBL] [Abstract][Full Text] [Related]
3. Does metabolic syndrome have an impact on the quality of life and mood of hemodialysis patients?
Afsar B; Elsurer R; Sezer S; Ozdemir NF
J Ren Nutr; 2009 Sep; 19(5):365-71. PubMed ID: 19464928
[TBL] [Abstract][Full Text] [Related]
4. Effect of omega-3 fatty acids supplementation on depressive symptoms and on health-related quality of life in the treatment of elderly women with depression: a double-blind, placebo-controlled, randomized clinical trial.
Rondanelli M; Giacosa A; Opizzi A; Pelucchi C; La Vecchia C; Montorfano G; Negroni M; Berra B; Politi P; Rizzo AM
J Am Coll Nutr; 2010 Feb; 29(1):55-64. PubMed ID: 20595646
[TBL] [Abstract][Full Text] [Related]
5. The effect of omega-3 fatty acids on depressive symptoms and inflammatory markers in maintenance hemodialysis patients: a randomized, placebo-controlled clinical trial.
Gharekhani A; Khatami MR; Dashti-Khavidaki S; Razeghi E; Noorbala AA; Hashemi-Nazari SS; Mansournia MA
Eur J Clin Pharmacol; 2014 Jun; 70(6):655-65. PubMed ID: 24643636
[TBL] [Abstract][Full Text] [Related]
6. Emotional distress and health-related quality of life in patients on hemodialysis: the clinical value of COOP-WONCA charts.
Arenas MD; Alvarez-Ude F; Reig-Ferrer A; Zito JP; Gil MT; Carretón MA; Albiach B; Moledous A
J Nephrol; 2007; 20(3):304-10. PubMed ID: 17557263
[TBL] [Abstract][Full Text] [Related]
7. Effects of oral supplementation with omega-3 fatty acids on nutritional state and inflammatory markers in maintenance hemodialysis patients.
Gharekhani A; Khatami MR; Dashti-Khavidaki S; Razeghi E; Abdollahi A; Hashemi-Nazari SS; Mansournia MA
J Ren Nutr; 2014 May; 24(3):177-85. PubMed ID: 24613294
[TBL] [Abstract][Full Text] [Related]
8. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.
da Silva TM; Munhoz RP; Alvarez C; Naliwaiko K; Kiss A; Andreatini R; Ferraz AC
J Affect Disord; 2008 Dec; 111(2-3):351-9. PubMed ID: 18485485
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study.
Nemets H; Nemets B; Apter A; Bracha Z; Belmaker RH
Am J Psychiatry; 2006 Jun; 163(6):1098-100. PubMed ID: 16741212
[TBL] [Abstract][Full Text] [Related]
10. Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial.
Sinn N; Milte CM; Street SJ; Buckley JD; Coates AM; Petkov J; Howe PR
Br J Nutr; 2012 Jun; 107(11):1682-93. PubMed ID: 21929835
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial.
Carney RM; Freedland KE; Rubin EH; Rich MW; Steinmeyer BC; Harris WS
JAMA; 2009 Oct; 302(15):1651-7. PubMed ID: 19843899
[TBL] [Abstract][Full Text] [Related]
12. Health-related qualıty of lıfe, sleep qualıty, and depressıon in peritoneal dialysis and hemodıalysıs patıents.
Turkmen K; Yazici R; Solak Y; Guney I; Altintepe L; Yeksan M; Tonbul HZ
Hemodial Int; 2012 Apr; 16(2):198-206. PubMed ID: 22136456
[TBL] [Abstract][Full Text] [Related]
13. ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial.
Torkildsen O; Wergeland S; Bakke S; Beiske AG; Bjerve KS; Hovdal H; Midgard R; Lilleås F; Pedersen T; Bjørnarå B; Dalene F; Kleveland G; Schepel J; Olsen IC; Myhr KM
Arch Neurol; 2012 Aug; 69(8):1044-51. PubMed ID: 22507886
[TBL] [Abstract][Full Text] [Related]
14. Potential Effects of Omega-3 Fatty Acids on Insulin Resistance and Lipid Profile in Maintenance Hemodialysis Patients: a Randomized Placebo-Controlled Trial.
Gharekhani A; Dashti-Khavidaki S; Lessan-Pezeshki M; Khatami MR
Iran J Kidney Dis; 2016 Sep; 10(5):310-318. PubMed ID: 27721230
[TBL] [Abstract][Full Text] [Related]
15. Eicosapentaenoic acid versus docosahexaenoic acid in mild-to-moderate depression: a randomized, double-blind, placebo-controlled trial.
Mozaffari-Khosravi H; Yassini-Ardakani M; Karamati M; Shariati-Bafghi SE
Eur Neuropsychopharmacol; 2013 Jul; 23(7):636-44. PubMed ID: 22910528
[TBL] [Abstract][Full Text] [Related]
16. Short-term consumption of oral omega-3 and dry eye syndrome.
Kangari H; Eftekhari MH; Sardari S; Hashemi H; Salamzadeh J; Ghassemi-Broumand M; Khabazkhoob M
Ophthalmology; 2013 Nov; 120(11):2191-6. PubMed ID: 23642375
[TBL] [Abstract][Full Text] [Related]
17. Dietary omega-3 fatty acid supplementation and naproxen treatment in patients with rheumatoid arthritis.
Kjeldsen-Kragh J; Lund JA; Riise T; Finnanger B; Haaland K; Finstad R; Mikkelsen K; Førre O
J Rheumatol; 1992 Oct; 19(10):1531-6. PubMed ID: 1464864
[TBL] [Abstract][Full Text] [Related]
18. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life in the patients on maintenance hemodialysis: the analysis of demographic and clinical factors.
Germin-Petrović D; Mesaros-Devcić I; Lesac A; Mandić M; Soldatić M; Vezmar D; Petrić D; Vujicić B; Basić-Jukić N; Racki S
Coll Antropol; 2011 Sep; 35(3):687-93. PubMed ID: 22053542
[TBL] [Abstract][Full Text] [Related]
20. Long-Chain Omega-3 Fatty Acid Supplements in Depressed Heart Failure Patients: Results of the OCEAN Trial.
Jiang W; Whellan DJ; Adams KF; Babyak MA; Boyle SH; Wilson JL; Patel CB; Rogers JG; Harris WS; O'Connor CM
JACC Heart Fail; 2018 Oct; 6(10):833-843. PubMed ID: 30098961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
